Week Peak Amid Strong Analyst Backing

Visa's stock rose 2.6% to $380.52, a 52-week high, driven by strong Q3 2026 results, institutional buying, and raised price targets. The company reported $11.6B revenue and $3.32 EPS, beating estimates. Bill Ackman's $1.1B stake also boosted sentiment. Mastercard also gained, while broader markets were mixed.

Pershing Square Capital Management disclosed a $1.12B stake in Visa (5.4% of portfolio) and new positions in Mastercard and S&P Global, totaling $3B. Visa reported Q3 2026 revenue of $11.6B (+14% YoY) and EPS up 11%. The company is expanding into AI-driven commerce and stablecoin infrastructure.

Visa shares closed 0.8% below their all-time high despite a 33% increase in services revenue, which now accounts for a third of its quarterly revenue. The company's stock rose 1.45% on Friday to $371.04, with a market value increase of nearly $10 billion. Visa's operating expenses rose 19%, outpacing revenue growth. The company announced a $2.4 billion acquisition of BioCatch to enhance fraud prevention. Analysts are bullish, with a consensus price target of $422.25, suggesting a 13.8% potential

Visa's shares rose 1.45% to $371.04 on Friday, near its all-time high, with four consecutive sessions of gains. Trading volume was 17% below average. Analysts' average price target is $416.20, implying 12.17% upside. Visa reported Q3 revenue of $11.6B, up 14%, and earnings of $3.32 per share, up 11%. The company announced a $0.67 quarterly dividend and a $2.4B acquisition of BioCatch. Risks include consumer spending, regulatory issues, and integration challenges.

Donald Trump's June financial disclosure shows 1,051 trades, with purchases exceeding $49M and sales of at least $28.5M. Notable buys include Berkshire Hathaway, Visa, Mastercard, and Cintas, while Meta Platforms and Motorola were sold. The largest transaction was a $5M-$25M sale of VIG ETF. Trump's accounts made 21,000 trades in 2025, managed by his children. The June 18 trades followed a market selloff triggered by a Federal Reserve meeting.

Visa will acquire fraud-intelligence company BioCatch for $2.4 billion, aiming to enhance its fraud prevention capabilities. BioCatch's technology analyzes behavioral and device data to detect scams in real time. The deal is expected to close by the end of Visa's fiscal second quarter in 2027, subject to regulatory approval. Visa's investment reflects the growing importance of fraud intelligence in the payments industry.